Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Epigallocatechingallate (EGCG) in Cardiac AL Amyloidosis (EpiCardiAL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2016 by IRCCS Policlinico S. Matteo
Sponsor:
Information provided by (Responsible Party):
Giampaolo Merlini, IRCCS Policlinico S. Matteo
ClinicalTrials.gov Identifier:
NCT01511263
First received: January 10, 2012
Last updated: February 24, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)